From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Liti.

United States District Court, D. Columbia
Jun 17, 2002
Civ. No. 004269 (TFH), MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH) (D.D.C. Jun. 17, 2002)

Opinion

Civ. No. 004269 (TFH), MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH)

June 17, 2002


ORDER


At the last status hearing held for all actions in this MDL case on May 28, 2002, which Plaintiff Health Plus of Michigan failed to attend, the Court set down another status hearing for all actions on Thursday, July 25, 2002 at 1:30 p.m. Accordingly, it is hereby

ORDERED that Plaintiff Health Plus of Michigan shall attend the status hearing on Thursday, July 25, 2002 at 1:30 p.m. It is further

ORDERED that the parties in this specific action, as captioned above, Civil Case Number 00-1269, shall file with the Court by no later than Wednesday, July 3, 2002 a report detailing the progress of this case since it was transferred to, and filed with, this Court on July 19, 2001 and its current status.


Summaries of

In re Lorazepam Clorazepate Antitrust Liti.

United States District Court, D. Columbia
Jun 17, 2002
Civ. No. 004269 (TFH), MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH) (D.D.C. Jun. 17, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Liti.

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION HEALTH PLUS OF MICHIGAN…

Court:United States District Court, D. Columbia

Date published: Jun 17, 2002

Citations

Civ. No. 004269 (TFH), MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH) (D.D.C. Jun. 17, 2002)